肠道激素和炎症性肠道疾病
1Department of Medicine, Tufts Medical Center, Boston, MA 02111, USA.
Biomolecules
|July 29, 2025
概括
肠道激素如GLP-1和GIP调节新陈代谢和免疫力,提供潜在的IBD治疗方法. 组合疗法具有前景,但需要更多的临床研究来确定肥胖患者的安全性和有效性.
科学领域:
- 胃肠病学 胃肠病学
- 代谢研究研究 代谢研究
- 免疫学 免疫学 免疫学
背景情况:
- 肥胖引起的炎症损害了肠道屏障的完整性,导致炎症性肠病 (IBD).
- 肠道激素,包括葡萄糖类-1 (GLP-1),葡萄糖类-2 (GLP-2),依赖葡萄糖的胰岛素多 (GIP),YY (PYY),胆固醇基因 (CCK) 和阿波利波蛋白A4 (APOA4),是宿主代谢和粘膜免疫的关键调节者.
- 这些激素为IBD管理提供了潜在的治疗途径.
研究的目的:
- 审查肠道激素影响肠道屏障功能和免疫力的已知机制.
- 探索向肠道激素用于IBD治疗的治疗潜力,特别是在肥胖和代谢功能障碍的背景下.
- 讨论肠道激素之间的协同相互作用及其对组合疗法的影响.
主要方法:
- 关于肠道激素及其在IBD中的作用的临床前和临床研究的文献综述.
- 分析涉及GLP-1,GLP-2,GIP,PYY,CCK和APOA4在肠道健康和炎症中的机制.
- 对组合激素疗法的证据评估及其临床应用.
主要成果:
- 在临床前模型中,GLP-1,GLP-2,GIP,PYY,CCK和APOA4对肠道屏障完整性,上皮细胞修复,免疫调节和炎症减轻具有有益影响.
- 与同时使用或间接相互作用 (例如,PYY刺激的APOA4) 观察到的协同效应表明治疗效益增强.
- 双重GIP/GLP-1受体激动剂显示代谢和炎症改善,但在临床使用中与胃肠道副作用有关.
结论:
- 肠道激素对IBD具有显著的治疗前景,特别是在肥胖或代谢问题患者中.
- 组合激素疗法可能提供更高的疗效,但需要进一步的研究来优化策略和确保安全.
- 未来的临床试验应侧重于评估组合疗法,理解共享途径,并为IBD患者量身定制治疗方法.
相关概念视频
01:17Irritable Bowel Syndrome I: Introduction
390
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
390
01:30Inflammatory Bowel Disease II: Crohn's Disease
387
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
387
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
422
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
422
01:29Inflammatory Bowel Disease IV: Pharmacological Management
193
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
193
01:17Chronic Bowel Disorders: Introduction
541
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
541
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
326
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
326